Reddit, Inc. Income Taxes Disclosure
| Year ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (in thousands) | |||||||||||||||||
| Domestic income (loss) | $ | 514,826 | $ | (493,371) | $ | (92,627) | |||||||||||
| Foreign income (loss) | 13,864 | 8,164 | 5,604 | ||||||||||||||
| Income (loss) before income taxes | $ | 528,690 | $ | (485,207) | $ | (87,023) | |||||||||||
| Year ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (in thousands) | |||||||||||||||||
| Current income tax expense (benefit): | |||||||||||||||||
| Federal | $ | — | $ | (141) | $ | 1,290 | |||||||||||
| State | 889 | 474 | 1,133 | ||||||||||||||
| Foreign | 2,707 | 851 | 1,468 | ||||||||||||||
| Total current income tax expense (benefit) | 3,596 | 1,184 | 3,891 | ||||||||||||||
| Deferred income tax expense (benefit): | |||||||||||||||||
| Federal | — | (237) | — | ||||||||||||||
| Foreign | (4,627) | (1,878) | (90) | ||||||||||||||
| Total deferred income tax expense (benefit) | (4,627) | (2,115) | (90) | ||||||||||||||
Total income tax expense (benefit): | |||||||||||||||||
Federal | — | (378) | 1,290 | ||||||||||||||
State | 889 | 474 | 1,133 | ||||||||||||||
Foreign | (1,920) | (1,027) | 1,378 | ||||||||||||||
| Total income tax expense (benefit) | $ | (1,031) | $ | (931) | $ | 3,801 | |||||||||||
Year ended December 31, 2025 | |||||||||||
Amount | Percent | ||||||||||
(in thousands, except percentages) | |||||||||||
| Provision for income taxes at statutory federal income tax rate | $ | 111,025 | 21.0 | % | |||||||
State income taxes, net of federal income tax effect(1) | 955 | 0.2 | |||||||||
| Foreign tax effects: | |||||||||||
| United Kingdom: | |||||||||||
| Stock-based compensation | (5,851) | (1.1) | |||||||||
| Other | (698) | (0.1) | |||||||||
| Other foreign jurisdictions | 70 | — | |||||||||
| Tax credits: | |||||||||||
| Research and development credits | (57,630) | (10.9) | |||||||||
| Change in valuation allowance | 172,418 | 32.6 | |||||||||
| Non-taxable or non-deductible items: | |||||||||||
| Stock-based compensation | (285,955) | (54.1) | |||||||||
| Non-deductible compensation | 69,402 | 13.1 | |||||||||
| Other non-taxable or non-deductible items | 1,299 | 0.3 | |||||||||
| Other reconciling items: | |||||||||||
| Return to provision true-ups | (6,317) | (1.2) | |||||||||
| Other | 251 | — | |||||||||
| Total tax provision and effective tax rate | $ | (1,031) | (0.2) | % | |||||||
| Year ended December 31, | |||||||||||
| 2024 | 2023 | ||||||||||
| Statutory federal income tax rate | 21.0 | % | 21.0 | % | |||||||
| State income taxes, net of federal benefit | 5.3 | 1.2 | |||||||||
Non-deductible compensation | (14.0) | — | |||||||||
| Stock-based compensation | 44.4 | 3.9 | |||||||||
| Research and development credits | 14.6 | 13.5 | |||||||||
| Change in valuation allowance | (71.0) | (41.1) | |||||||||
| Other | (0.2) | (2.9) | |||||||||
| Effective tax rate | 0.1 | % | (4.4) | % | |||||||
| December 31, 2025 | December 31, 2024 | ||||||||||
| (in thousands) | |||||||||||
| Deferred tax assets: | |||||||||||
| Net operating loss carryforwards | $ | 404,212 | $ | 149,735 | |||||||
| Stock-based compensation | 16,920 | 28,586 | |||||||||
| Lease liability | 5,634 | 6,206 | |||||||||
| Capitalized research and development costs | 156,429 | 268,232 | |||||||||
| Research and development credits | 199,017 | 124,116 | |||||||||
| Other | 12,103 | 13,351 | |||||||||
| Gross deferred tax assets | 794,315 | 590,226 | |||||||||
| Valuation allowance | (779,030) | (572,894) | |||||||||
| Total deferred tax assets, net of valuation allowance | 15,285 | 17,332 | |||||||||
| Deferred tax liabilities: | |||||||||||
| Right-of-use asset | (4,941) | (5,436) | |||||||||
| Acquired intangibles | (3,556) | (9,727) | |||||||||
| Total deferred tax liabilities | (8,497) | (15,163) | |||||||||
| Net deferred tax assets (liabilities) | $ | 6,788 | $ | 2,169 | |||||||
| Year ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (in thousands) | |||||||||||||||||
| Beginning balance of unrecognized tax benefits | $ | 43,861 | $ | 19,236 | $ | 16,428 | |||||||||||
| Increases/(decreases) related to prior year tax positions | 7,434 | 1,444 | (1,750) | ||||||||||||||
| Increases/(decreases) related to current year tax positions | 19,115 | 23,181 | 4,558 | ||||||||||||||
| Ending balance of unrecognized tax benefits | $ | 70,410 | $ | 43,861 | $ | 19,236 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 6, 2026 | Showing above |
| 2024 | Feb 13, 2025 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.